Tower Research Capital (TRC)’s NeuroOne Medical Technologies NMTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85K | Buy |
+8,629
| New | +$5.85K | ﹤0.01% | 4145 |
|
|
2025
Q1 | – | Sell |
-5,747
| Closed | -$4.75K | – | 5600 |
|
|
2024
Q4 | $4.75K | Buy |
5,747
+1,401
| +32% | +$1.16K | ﹤0.01% | 4404 |
|
|
2024
Q3 | $4.3K | Sell |
4,346
-7,057
| -62% | -$6.99K | ﹤0.01% | 4593 |
|
|
2024
Q2 | $9.12K | Buy |
11,403
+4,401
| +63% | +$3.52K | ﹤0.01% | 4286 |
|
|
2024
Q1 | $8.4K | Buy |
7,002
+1,865
| +36% | +$2.24K | ﹤0.01% | 4025 |
|
|
2023
Q4 | $8.12K | Buy |
+5,137
| New | +$8.12K | ﹤0.01% | 4542 |
|
|
2023
Q3 | – | Sell |
-10,234
| Closed | -$12.3K | – | 6127 |
|
|
2023
Q2 | $12.3K | Buy |
10,234
+4,832
| +89% | +$5.8K | ﹤0.01% | 3864 |
|
|
2023
Q1 | $8K | Buy |
5,402
+1,302
| +32% | +$1.93K | ﹤0.01% | 4645 |
|
|
2022
Q4 | $5K | Sell |
4,100
-1,350
| -25% | -$1.65K | ﹤0.01% | 4887 |
|
|
2022
Q3 | $9K | Buy |
5,450
+45
| +0.8% | +$74 | ﹤0.01% | 4671 |
|
|
2022
Q2 | $4K | Buy |
+5,405
| New | +$4K | ﹤0.01% | 5235 |
|
|
2022
Q1 | – | Sell |
-286
| Closed | -$1K | – | 6413 |
|
|
2021
Q4 | $1K | Sell |
286
-4,621
| -94% | -$16.2K | ﹤0.01% | 5864 |
|
|
2021
Q3 | $20K | Buy |
+4,907
| New | +$20K | ﹤0.01% | 3715 |
|